These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 14636085

  • 1. Levosimendan: a review of its use in the management of acute decompensated heart failure.
    Innes CA, Wagstaff AJ.
    Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085
    [Abstract] [Full Text] [Related]

  • 2. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M, Lehtonen L.
    Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
    [Abstract] [Full Text] [Related]

  • 3. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y.
    Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
    [Abstract] [Full Text] [Related]

  • 4. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL, Fitzpatrick JT.
    Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
    [Abstract] [Full Text] [Related]

  • 5. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG, Nikitin N, McGowan J.
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [Abstract] [Full Text] [Related]

  • 6. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
    Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Põder P, Kivikko M, SURVIVE Investigators.
    JAMA; 2007 May 02; 297(17):1883-91. PubMed ID: 17473298
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
    Cleland JG, Takala A, Apajasalo M, Zethraeus N, Kobelt G.
    Eur J Heart Fail; 2003 Jan 02; 5(1):101-8. PubMed ID: 12559222
    [Abstract] [Full Text] [Related]

  • 10. Levosimendan: dual mechanisms for acute heart failure...and beyond?
    Ng TM, Akhter MW.
    Minerva Cardioangiol; 2005 Dec 02; 53(6):565-84. PubMed ID: 16333239
    [Abstract] [Full Text] [Related]

  • 11. Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril.
    Antila S, Eha J, Heinpalu M, Lehtonen L, Loogna I, Mesikepp A, Planken U, Sandell EP.
    Eur J Clin Pharmacol; 1996 Dec 02; 49(6):451-8. PubMed ID: 8706769
    [Abstract] [Full Text] [Related]

  • 12. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J.
    Hellenic J Cardiol; 2007 Dec 02; 48(2):80-8. PubMed ID: 17489345
    [Abstract] [Full Text] [Related]

  • 13. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan, a new calcium-sensitizing inotrope for heart failure.
    Ng TM.
    Pharmacotherapy; 2004 Oct 01; 24(10):1366-84. PubMed ID: 15628834
    [Abstract] [Full Text] [Related]

  • 15. Levosimendan: a parenteral calcium-sensitising drug with additional vasodilatory properties.
    Lehtonen LA.
    Expert Opin Investig Drugs; 2001 May 01; 10(5):955-70. PubMed ID: 11322869
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
    García González MJ, Domínguez Rodríguez A.
    Am J Cardiovasc Drugs; 2006 May 01; 6(2):69-75. PubMed ID: 16555860
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
    Wang L, Cui L, Wei JP, Li GP, Qi GX, Hao YM, Wang WZ, Li HM, Liu J, Jiang DJ, Zhang YD.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun 01; 38(6):527-30. PubMed ID: 21033135
    [Abstract] [Full Text] [Related]

  • 18. Levosimendan.
    Figgitt DP, Gillies PS, Goa KL.
    Drugs; 2001 Jun 01; 61(5):613-27; discussion 628-9. PubMed ID: 11368286
    [Abstract] [Full Text] [Related]

  • 19. Levosimendan compared with dobutamine in low output patients.
    Nieminen MS.
    Minerva Anestesiol; 2003 Apr 01; 69(4):258-63. PubMed ID: 12766717
    [Abstract] [Full Text] [Related]

  • 20. Levosimendan: a new dual-action drug in the treatment of acute heart failure.
    Mebazaa A, Erhardt L.
    Int J Clin Pract; 2003 Jun 01; 57(5):410-6. PubMed ID: 12846347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.